Cascade Pharmaceuticals

Shanghai-based sino-foreign joint venture, Cascade Pharmaceuticals, Inc., has reportedly raised RMB140 million in a recent financing round. The investors included a prestigious group of Puhua Capital, CAS Investment, HD Capital, Lapam Capital, and New Act Investment. The funds raised will be directed towards intensifying Phase II clinical studies for their…